البلد: الولايات المتحدة
اللغة: الإنجليزية
المصدر: NLM (National Library of Medicine)
DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302)
AX Pharmaceutical Corp
DAPSONE
DAPSONE 49.5 g in 50 g
NOT APPLICABLE
Bulk Ingredient For Animal Drug Compounding
AX PHARMACEUTICAL CORP- DAPSONE POWDER AX PHARMACEUTICAL CORP ---------- AX PHARMACEUTICAL CORP dapsone powder AX Pharmaceutical Corp PRODUCT INFORMATION PRODUCT T YPE BULK INGREDIENT ITE M CODE (SOURCE ) NDC:6 2157-46 9 ROUTE OF ADMINISTRATION NOT APPLICABLE ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DAPSO NE (UNII: 8 W5C518 30 2) (DAPSONE - UNII:8 W5C518 30 2) DAPSONE 49 .5 g in 50 g INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH WATER (UNII: 0 59 QF0 KO0 R) PRODUCT CHARACTERISTICS COLOR white S CORE S HAP E S IZ E FLAVOR IMPRINT CODE CONTAINS PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:6 2157-46 9 -0 1 50 g in 1 JAR 0 8 /22/20 17 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITA TIO N MARKE TING START DATE MARKE TING END DATE bulk ingredient fo r animal drug c o mpo unding 0 8 /22/20 17 LABELER - AX Pharmaceutical Corp (202924858) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS AX Pharmaceutical Co rp 20 29 248 58 repack(6 2157-46 9 ) , relabel(6 2157-46 9 ) Revised: 8/2017 اقرأ الوثيقة كاملة